Alzheimer Mainstream

Two things amazed me when I read the article by Christine Bahls on Alzheimer research.1 Certainly the huge amount of funding [was one]. Also the fact that, as far as I could see, no research appears to be directed toward identifying whether any infective processes are involved. I am not the only one who believes that many of the diseases we have termed idiopathic, meaning the cause of the disease had not been elucidated, are indeed of infective origin. In the last few years many diseases branded

Written byEdward Mcneil
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

I am not the only one who believes that many of the diseases we have termed idiopathic, meaning the cause of the disease had not been elucidated, are indeed of infective origin. In the last few years many diseases branded as idiopathic have turned out to be of an infective origin, the best known being peptic ulceration. Cases of multiple sclerosis (MS), fibromyalgia (FM), and chronic fatigue syndrome (CFS) are increasing in prevalence, and the increase cannot be attributed to an aging population; the age at which the diseases are being diagnosed has diminished. With the possibility that infective agents are responsible, it is prudent to ask which infectious diseases are becoming more prevalent and could they be related to the increase in one or more of the idiopathic diseases. Tick-borne diseases are second only to HIV infections in the United States as regards increasing numbers, and they are increasing ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies